SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

INOVIO Reports Third-Quarter 2026 Financial Results

INOVIO announced its financial results for the third quarter of 2026.

INO
SquawkNews Desk

PLYMOUTH MEETING, Pa., Nov. 10, 2026 // -- INOVIO (NASDAQ:INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the third qua…

Related stories

Blackstone Infrastructure to Acquire Portland Natural Gas Transmission System M impact | EQUITY | Nov 10, 2026, 10:07 PM UTC Andean Precious Metals Reports $197M Q3 Revenue, Cuts Golden Queen Output Guidance The company reported Q3 2026 net income of $32M and operating cash flow of $72M. Golden Queen production guidance fell to 37,000–40,000 oz from 43,000–50,000 oz, while cost guidanc M impact | EQUITY | Nov 10, 2026, 10:02 PM UTC Graco enters $600 million accelerated share repurchase agreement Graco entered into a $600 million accelerated share repurchase agreement with Bank of America. M impact | EQUITY | Nov 10, 2026, 10:02 PM UTC Total Energy Services Reports C$342.9M in Third-Quarter Revenue M impact | EQUITY | Nov 10, 2026, 10:01 PM UTC NovaGold shares to cease NYSE American trading Dec. 1; TSX delisting to follow M impact | EQUITY | Nov 10, 2026, 10:01 PM UTC US Stocks Fell as Hot Inflation Lifted Bond Yields US stocks fell on Tuesday after unexpectedly hot inflation drove bond yields higher and strengthened expectations for faster interest-rate increases. The move outweighed oil’s decl M impact | EQUITY | Nov 10, 2026, 10:00 PM UTC